Your browser doesn't support javascript.
loading
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands.
Gechijian, Lara N; Buckley, Dennis L; Lawlor, Matthew A; Reyes, Jaime M; Paulk, Joshiawa; Ott, Christopher J; Winter, Georg E; Erb, Michael A; Scott, Thomas G; Xu, Mousheng; Seo, Hyuk-Soo; Dhe-Paganon, Sirano; Kwiatkowski, Nicholas P; Perry, Jennifer A; Qi, Jun; Gray, Nathanael S; Bradner, James E.
Afiliação
  • Gechijian LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Buckley DL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lawlor MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Reyes JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Paulk J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ott CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Winter GE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Erb MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Scott TG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Xu M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Seo HS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Dhe-Paganon S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kwiatkowski NP; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • Perry JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Qi J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gray NS; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Bradner JE; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.
Nat Chem Biol ; 14(4): 405-412, 2018 04.
Article em En | MEDLINE | ID: mdl-29507391
ABSTRACT
The addressable pocket of a protein is often not functionally relevant in disease. This is true for the multidomain, bromodomain-containing transcriptional regulator TRIM24. TRIM24 has been posited as a dependency in numerous cancers, yet potent and selective ligands for the TRIM24 bromodomain do not exert effective anti-proliferative responses. We therefore repositioned these probes as targeting features for heterobifunctional protein degraders. Recruitment of the VHL E3 ubiquitin ligase by dTRIM24 elicits potent and selective degradation of TRIM24. Using dTRIM24 to probe TRIM24 function, we characterize the dynamic genome-wide consequences of TRIM24 loss on chromatin localization and gene control. Further, we identify TRIM24 as a novel dependency in acute leukemia. Pairwise study of TRIM24 degradation versus bromodomain inhibition reveals enhanced anti-proliferative response from degradation. We offer dTRIM24 as a chemical probe of an emerging cancer dependency, and establish a path forward for numerous selective yet ineffectual ligands for proteins of therapeutic interest.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Transporte Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Transporte Idioma: En Ano de publicação: 2018 Tipo de documento: Article